Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy

MLA

Sezen, Duygu; Selek, Uğur (ORCID 0000-0001-8087-3140 &.YÖK ID 27211), et al. “Baseline Hemoglobin <11.0 g/DL Has Stronger Prognostic Value than Anemia Status in Nasopharynx Cancers Treated with Chemoradiotherapy.” International Journal of Biological Markers, 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1200731265&authtype=sso&custid=ns315887.

APA

Sezen, D. S. U. (ORCID 0000-0001-8087-3140 & Y. I. 27211), Topkan, E. E. N. Y. O. Y. B. A. A. Y. B. A. M. H., School of Medicine, & Department of Radiation Oncology. (2019). Baseline hemoglobin <11.0 g/dL has stronger prognostic value than anemia status in nasopharynx cancers treated with chemoradiotherapy. International Journal of Biological Markers.

Chicago

Sezen, Duygu; Selek, Uğur (ORCID 0000-0001-8087-3140 & YÖK ID 27211), Erkan; Ekici, Nur Yücel; Özdemir, Yurday; Besen, Ali Ayberk; Yıldırım, Berna Akkuş; Mertsoylu, Hüseyin Topkan, School of Medicine, and Department of Radiation Oncology. 2019. “Baseline Hemoglobin <11.0 g/DL Has Stronger Prognostic Value than Anemia Status in Nasopharynx Cancers Treated with Chemoradiotherapy.” International Journal of Biological Markers. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1200731265&authtype=sso&custid=ns315887.